Search research articles
Contact Us
Filters
Showing results (31-40 of 37) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 37 results.
Scientific Reports
|
January 31, 2025
Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism
Christian X Fay, Elizabeth R M Zunica, Elias Awad, et al.
Molecular Therapy. Nucleic Acids
|
April 18, 2022
Targeted exon skipping of <i>NF1</i> exon 17 as a therapeutic for neurofibromatosis type I
André Leier, Marc Moore, Hui Liu, et al.
Molecular Therapy. Oncology
|
April 6, 2026
Identification of small molecules that enhance aminoglycoside-mediated suppression of <i>CFTR</i> and <i>NF1</i> nonsense mutations
Joshua Sammons, Jianguo Chen, Kari Thrasher, et al.
Plos One
|
March 10, 2026
Correction: Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas
Hua Li, Alexander Pemov, Robert Allaway, et al.
Plos One
|
January 21, 2026
Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas
Hua Li, Alexander Pemov, Robert Allaway, et al.
Cell
|
July 4, 2017
Development of a Novel Lead that Targets M. tuberculosis Polyketide Synthase 13
Anup Aggarwal, Maloy K Parai, Nishant Shetty, et al.
Translational Psychiatry
|
January 31, 2019
ADGRL3 (LPHN3) variants predict substance use disorder
Mauricio Arcos-Burgos, Jorge I Vélez, Ariel F Martinez, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 37) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 37 results.
Scientific Reports
|
January 31, 2025
Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism
Christian X Fay, Elizabeth R M Zunica, Elias Awad, et al.
Molecular Therapy. Nucleic Acids
|
April 18, 2022
Targeted exon skipping of <i>NF1</i> exon 17 as a therapeutic for neurofibromatosis type I
André Leier, Marc Moore, Hui Liu, et al.
Molecular Therapy. Oncology
|
April 6, 2026
Identification of small molecules that enhance aminoglycoside-mediated suppression of <i>CFTR</i> and <i>NF1</i> nonsense mutations
Joshua Sammons, Jianguo Chen, Kari Thrasher, et al.
Plos One
|
March 10, 2026
Correction: Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas
Hua Li, Alexander Pemov, Robert Allaway, et al.
Plos One
|
January 21, 2026
Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas
Hua Li, Alexander Pemov, Robert Allaway, et al.
Cell
|
July 4, 2017
Development of a Novel Lead that Targets M. tuberculosis Polyketide Synthase 13
Anup Aggarwal, Maloy K Parai, Nishant Shetty, et al.
Translational Psychiatry
|
January 31, 2019
ADGRL3 (LPHN3) variants predict substance use disorder
Mauricio Arcos-Burgos, Jorge I Vélez, Ariel F Martinez, et al.
Page
of 4